How Important Is Novavax's COVID Vaccine Manufacturing Deal With GlaxoSmithKline?

GlaxoSmithKline (NYSE: GSK) has teamed up with several other companies to develop COVID-19 vaccine candidates. However, the big drugmaker is also helping support the manufacturing of Novavax's (NASDAQ: NVAX) COVID-19 vaccine -- a vaccine for which it was completely uninvolved in the development. In this Motley Fool Live video, recorded on March 31, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss how important this manufacturing deal with GlaxoSmithKline is for Novavax.

Continue reading

Source Fool.com